Terms: = Uterine cancer AND ARID1B, 6A3-5, 57492, ENSG00000049618, p250R, KIAA1235, ELD/OSA1, DAN15, BRIGHT, BAF250b
80 results:
1. Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids.
Huang Y; Zhou S; Su Y; Pang Z; Cai S
Sci Rep; 2024 Apr; 14(1):9857. PubMed ID: 38684835
[TBL] [Abstract] [Full Text] [Related]
2. Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study.
Heremans R; Wynants L; Valentin L; Leone FPG; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Van den Bosch T;
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):556-563. PubMed ID: 37927006
[TBL] [Abstract] [Full Text] [Related]
3. Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.
Tessier-Cloutier B; Kommoss FKF; Kolin DL; Němejcová K; Smith D; Pors J; Stewart CJR; McCluggage WG; Foulkes WD; von Deimling A; Köbel M; Lee CH
Mod Pathol; 2024 Jan; 37(1):100374. PubMed ID: 37925057
[TBL] [Abstract] [Full Text] [Related]
4. Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/arid1b co-inactivated dedifferentiated endometrial carcinoma.
Wong NKY; Llaurado Fernandez M; Kommoss FKF; Praveen Kumar P; Kim H; Liu J; Zhang G; Coatham M; Lin YY; Haegert AM; Volik S; Le Bihan S; Collins CC; Fu Y; Postovit LM; von Deimling A; Wu R; Xue H; Wang Y; Köbel M; Carey MS; Lee CH
Gynecol Oncol; 2023 Sep; 176():162-172. PubMed ID: 37556934
[TBL] [Abstract] [Full Text] [Related]
5. TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.
Shi K; Liu XL; Guo Q; Zhang YQ; Fan ST; Dai L; Jiang N; Li D
PLoS One; 2023; 18(7):e0285817. PubMed ID: 37478120
[TBL] [Abstract] [Full Text] [Related]
6. Landscape of chromatin remodeling gene alterations in endometrial carcinoma.
Momeni-Boroujeni A; Vanderbilt C; Yousefi E; Abu-Rustum NR; Aghajanian C; Soslow RA; Ellenson LH; Weigelt B; Murali R
Gynecol Oncol; 2023 May; 172():54-64. PubMed ID: 36958196
[TBL] [Abstract] [Full Text] [Related]
7. Dedifferentiated Ovarian Carcinoma with ARID1A and arid1b Mutations: A Clinicopathological Report and Literature Review.
Kamal M; Atwi D; Pang H; Li S; Hassell L
Int J Surg Pathol; 2023 Dec; 31(8):1526-1531. PubMed ID: 36843546
[TBL] [Abstract] [Full Text] [Related]
8. uterine junctional zone and adenomyosis: comparison of MRI, transvaginal ultrasound and histology.
Harmsen MJ; Trommelen LM; de Leeuw RA; Tellum T; Juffermans LJM; Griffioen AW; Thomassin-Naggara I; Van den Bosch T; Huirne JAF
Ultrasound Obstet Gynecol; 2023 Jul; 62(1):42-60. PubMed ID: 36370446
[TBL] [Abstract] [Full Text] [Related]
9. High MutS homolog 2 expression predicts poor prognosis and is related to immune infiltration in endometrial carcinoma.
Lu X; Ying Y; Zhang W; Li R; Zhang J
Cell Biol Int; 2023 Jan; 47(1):201-215. PubMed ID: 36208091
[TBL] [Abstract] [Full Text] [Related]
10. Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents.
Bagul C; Rao GK; Veena I; Kulkarni R; Tamboli JR; Akunuri R; Shaik SP; Pal-Bhadra M; Kamal A
Mol Divers; 2023 Jun; 27(3):1185-1202. PubMed ID: 36114912
[TBL] [Abstract] [Full Text] [Related]
11. Increased expression of TIGIT and KLRG1 correlates with impaired CD56
Nie Y; Liu D; Yang W; Li Y; Zhang L; Cheng X; Chen R; Yuan B; Zhang G; Wang H
Virol J; 2022 Apr; 19(1):68. PubMed ID: 35413989
[TBL] [Abstract] [Full Text] [Related]
12. Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression.
Tessier-Cloutier B; Kang EY; Alex D; Stewart CJR; McCluggage WG; Köbel M; Lee CH
Histopathology; 2022 Jul; 81(1):44-54. PubMed ID: 35394077
[TBL] [Abstract] [Full Text] [Related]
13. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3).
Heremans R; Van Den Bosch T; Valentin L; Wynants L; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Leone FPG;
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):243-255. PubMed ID: 35385178
[TBL] [Abstract] [Full Text] [Related]
14. Cellular context determines DNA methylation profiles in SWI/SNF-deficient cancers of the gynecologic tract.
Kommoss FK; Tessier-Cloutier B; Witkowski L; Forgo E; Koelsche C; Köbel M; Foulkes WD; Lee CH; Kolin DL; von Deimling A; Howitt BE
J Pathol; 2022 Jun; 257(2):140-145. PubMed ID: 35218556
[TBL] [Abstract] [Full Text] [Related]
15. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
[TBL] [Abstract] [Full Text] [Related]
16. Angiogenic Properties of NK Cells in cancer and Other Angiogenesis-Dependent Diseases.
Radomska-Leśniewska DM; Białoszewska A; Kamiński P
Cells; 2021 Jun; 10(7):. PubMed ID: 34209508
[TBL] [Abstract] [Full Text] [Related]
17. Clinical application of the 2011 IFCPC colposcope terminology.
Zhang B; Hong S; Zhang G; Rong F
BMC Womens Health; 2021 Jun; 21(1):257. PubMed ID: 34167543
[TBL] [Abstract] [Full Text] [Related]
18. Dedifferentiation in Breast Metastasis of Endometrial Carcinoma: A Diagnostic Dilemma.
Shah VI; Morgan SE; Köbel M; Lee CH; McCluggage WG
Int J Gynecol Pathol; 2022 Jan; 41(1):35-39. PubMed ID: 33741764
[TBL] [Abstract] [Full Text] [Related]
19. Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification.
Santoro A; Angelico G; Travaglino A; Raffone A; Arciuolo D; D'Alessandris N; Inzani F; Zannoni GF
Gynecol Oncol; 2021 May; 161(2):629-635. PubMed ID: 33712277
[TBL] [Abstract] [Full Text] [Related]
20. Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer.
Da Cruz Paula A; DeLair DF; Ferrando L; Fix DJ; Soslow RA; Park KJ; Chiang S; Reis-Filho JS; Zehir A; Donoghue MTA; Wu M; Brown DN; Murali R; Friedman CF; Zamarin D; Makker V; Mueller JJ; Leitao MM; Abu-Rustum NR; Aghajanian C; Weigelt B
Gynecol Oncol; 2021 May; 161(2):535-544. PubMed ID: 33622519
[TBL] [Abstract] [Full Text] [Related]
[Next]